Lifelong Enzyme Therapy: A Call for Policy Change
Published on: Feb. 6, 2026, 2:17 p.m. | Source: Devdiscourse
Maharashtra BJP MP Anil Sukheorao Bonde emphasized the need for lifelong enzyme replacement therapy for children with rare diseases. Under current policy, financial support is limited, risking treatment discontinuation. Bonde suggests using CSR and core funding for uninterrupted therapy, which is crucial for children's growth and health.
